Translational Biology
Moving a mechanism from cell and tissue observation to a human-relevant, testable programme without losing biological fidelity.
STRATEGIC SCIENTIFIC ADVISORY · AREAS OF EXPERTISE
SCIENTIFIC DOMAINS
Moving a mechanism from cell and tissue observation to a human-relevant, testable programme without losing biological fidelity.
Evaluation of repair, renewal, and stem-cell-adjacent approaches, with particular attention to what the evidence supports versus what the field asserts.
Follicular cycling, miniaturization, intracrine androgen dynamics, senescence, and immune privilege — an area of sustained published research.
Determining whether a proposed causal pathway is biologically plausible, adequately evidenced, and specific enough to defend.
Designing gene-expression work that answers a decision-relevant question, with appropriate controls, power, and pre-specified endpoints.
Structuring the evidence package — in vitro, ex vivo, and clinical — needed to support claims in regulated markets.
DEVELOPMENT & STRATEGY
Translating a validated mechanism into a manufacturable, stable, and commercially coherent product.
Delivery, bioavailability, ingredient interaction, and stability considered against regulatory and cost constraints from the outset.
Independent review of a technology, dossier, or licensing candidate before capital or reputation is committed.
Identifying what is genuinely novel and defensible, and shaping the research record so the claims can be supported.
Sequencing evidence, regulatory pathway, and channel strategy so each supports the next rather than being retrofitted.
Structuring licensing and distribution across jurisdictions with differing registration, labelling, and claim regimes.
SELECTIVE COLLABORATIONS
Each area of expertise is available as part of a selective advisory relationship.
Enquire about an advisory engagement